Imdelltra

Amgen

Pharma

Amgen’s Imdelltra scores overall survival win in first-line SCLC

Amgen's R&D chief Jay Bradner said the DLL3 drug stands to “further revolutionize the standard for survival earlier in the treatment journey.”

Angus Liu Sep 8, 2026 11:42am

deal handshake business cooperation partnerships

BeOne bags $885M in Royalty deal on Amgen's Imdelltra

Aug 25, 2025 10:34am

ASCO

ASCO: Amgen's Imdelltra prolongs life in small cell lung cancer

Jun 2, 2025 8:00am

Jazz and PharmaMar Zepzelca for small cell lung cancer

ASCO: Roche, Jazz lung cancer win leaves room for improvement

May 22, 2025 5:00pm

Amgen

Amgen touts phase 3 survival win for lung cancer drug Imdelltra

Apr 11, 2025 2:43pm

Asia

Merck-Curon, Legend, Amgen—Fierce Pharma Asia

Aug 16, 2024 8:59am